Linical is a global contract research organization (CRO), which provides the full spectrum of drug development services from early-stage to large-scale, multinational studies.
Linical has actively expanded around the world to become the first Japanese-headquartered global CRO capable of delivering a one-stop service for large-scale projects, with nearly 1,000 employees covering all key markets in Asia-Pacific, Europe, and North America.
Combining a strong business perspective with clinical and medical expertise, our team goes beyond operational excellence providing flexibility, guidance, and key strategies to successfully overcome drug development and regulatory procedures challenges. We strive to offer professional, high-quality services with the personal attention needed in a constantly evolving pharmaceutical and biotech market.
Linical is focused on addressing unmet medical needs in oncology, ommunology and central nervous system (CNS), also has a strong record of successfully delivered services in other areas, with strengths in infectious disease, endocrinology, and cystic fibrosis.
At Linical, we believe in supporting our clients throughout their unique clinical development journey, with a shared goal of bringing promising new therapies to patients all over the world.
We have the right size, the right reach, and the right team.
Let us support your journey, the right way.
Established in 2005 by a group of entrepreneurs at a major Japanese pharmaceutical company, our mission is to promote the greater wellbeing of all our stakeholders — patients, business partners, employees and shareholders — we strive constantly to offer professional, high-quality services to support all aspects of new drug development.
Linical Headquarters Europe
60528 Frankfurt am Main